CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioscience Brands Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioscience Brands Limited
4 Brewery Street, Johannesburg
Phone: +27 315817200p:+27 315817200 ISANDO, 1609  South Africa Fax: +27 315817209f:+27 315817209
Filed for Bankruptcy on 11/11/2013
On 11/11/2013, the North Gauteng High Court granted an order for the provisional winding up of the Company (the provisional order) pursuant to an application for winding up brought by Dr. AP Ferreira
On 11/17/2014, the Company was placed into final liquidation
This company is no longer actively traded on any major stock exchange.
Business Summary
Bioscience Brands Limited (BioScience Brands) is a holding company. The Company markets and sells products through a portfolio of brands in the health, wellness and sports nutrition market. The Company’s subsidiaries include Vitamology (Pty) Ltd, Rare Earth Minerals (Pty) Ltd, Aldabri 53 (Pty) Ltd and Bioharmony (Pty) Ltd. Effective from June 1, 2012, the Company disposed of its Nutrimax Brand.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20126/30/2012Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Interim Chief Executive Officer Jonathan J.Fenster 1/11/2013 9/10/2009
Financial Director, Director RichardJubber 3/1/2012 3/1/2012
Non-Executive Director YaseenBhayat 11/19/2007 11/19/2007
Non-Executive Director StephenSchutz 6/29/2011 4/30/2011

General Information
Stock Exchange: JNB
Fax Number: +27 315817209


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023